Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
Tianyin Pharmaceutical Co. reported its revenues rose 48%...
3SBio (沈阳三生制药) and Ascentage Pharma will...
Tianyin Pharmaceutical completed construction of its...
Sinopharm Group will pay $198 million for a 60% stake in...
Tianyin Pharma announced SFDA approval for a diabetes...
Chongqing Zhifei Biological Products bid $93 million for...
It's earnings season, and almost every day for the past...
ChinaBio® and EBD Group announced the fourth annual...
Tianyin Pharmaceuticals reported that its new production...
In 2011, the SFDA issued fewer drug approvals and allowed...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
